Stage of bleed based in ICH in CT /MRI brain
intracerebral hemorrhage AND imaging
intracerebral hemorrhage CT MRI staging hyperacute acute subacute chronic signal guidelines
| Stage | Approx. time | Main Hb form | Non-contrast CT | T1 MRI | T2 MRI / FLAIR | GRE/SWI |
|---|---|---|---|---|---|---|
| Hyperacute | <24 h | Intracellular oxyhemoglobin | Often hyperdense, though may be heterogeneous | Iso-/hypointense | Hyperintense | Marked susceptibility/blooming |
| Acute | 1-3 days | Intracellular deoxyhemoglobin | Hyperdense clot | Iso-/hypointense | Hypointense | Blooming |
| Early subacute | 3-7 days | Intracellular methemoglobin | Still hyperdense, gradually less dense | Hyperintense | Hypointense | Blooming |
| Late subacute | 1-4 weeks | Extracellular methemoglobin | Density falls, becomes isodense then hypodense | Hyperintense | Hyperintense | Peripheral low-signal rim/blooming |
| Chronic | >4 weeks | Hemosiderin/ferritin, encephalomalacia | Hypodense cavity or may become inapparent | Hypointense or CSF-like cavity | Hypointense hemosiderin rim with central CSF-like signal | Persistent marked blooming, hemosiderin rim |
Stage of bleed based in ICH in CT /MRI brain textbook based
intracerebral hemorrhage AND magnetic resonance imaging
intracerebral hemorrhage MRI stages hyperacute acute early late subacute chronic methemoglobin CT hyperdensity
| Stage | Time after bleed | Predominant blood product | T1-weighted MRI | T2-weighted MRI | Key point |
|---|---|---|---|---|---|
| Hyperacute | 0-24 h | Intracellular oxyhemoglobin, with evolving deoxyhemoglobin | Isointense | Predominantly hyperintense, but developing dark peripheral rim/foci | GRE/SWI may already show susceptibility from deoxyhemoglobin |
| Acute | 1-3 days | Intracellular deoxyhemoglobin | Isointense to mildly hypointense | Markedly hypointense | Classic dark T2 hematoma |
| Early subacute | 3 days-1 week | Intracellular methemoglobin | Hyperintense | Hypointense | T1 becomes bright first |
| Late subacute | 1-4 weeks | Extracellular methemoglobin | Hyperintense | Hyperintense | Both T1 and T2 become bright |
| Chronic | >4 weeks | Hemosiderin and ferritin at rim; central liquefaction/cavity in large bleeds | Central cavity: low T1, if present | Central cavity: high T2; dark peripheral rim | T2/GRE/SWI show persistent dark hemosiderin rim and blooming |
| CT phase | Typical appearance |
|---|---|
| Acute ICH | Hyperdense, well-defined hematoma |
| Days to weeks | Margin becomes irregular or “moth-eaten”; edema is hypodense; hematoma density progressively decreases |
| Resolving/chronic | Becomes isodense then hypodense; large hematomas may leave an encephalomalacic, low-density cavity with ex-vacuo enlargement of adjacent CSF spaces |